Literature DB >> 19215952

Type I IFN response to Papiine herpesvirus 2 (Herpesvirus papio 2; HVP2) determines neuropathogenicity in mice.

K M Rogers1, M Deatheridge, M A Breshears, S Chapman, D Black, J W Ritchey, M Payton, R Eberle.   

Abstract

Isolates of baboon alpha-herpesvirus Papiine herpesvirus 2 (HVP2) exhibit one of two distinct phenotypes in mice: extremely neurovirulent or apathogenic. Previous studies implicated the type I interferon (IFN) response as being a major factor in controlling infection by apathogenic isolates. To further investigate the possibility that the host IFN-beta response underlies the pathogenicity of the two HVP2 subtypes, the susceptibility of mice lacking the IFN-beta receptor (IFNAR(-/-)) to infection was examined. Apathogenic isolates of HVP2 (HVP2ap) replicated in IFNAR(-/-) primary mouse dermal fibroblast (PMDF) cultures as well as neurovirulent (HVP2nv) isolates. IFNAR(-/-) mice were also susceptible to lethal infection by HVP2ap isolates. Unlike Balb/c or parental 129 mice, LD(50) and ID(50) values for HVP2ap were the same in IFNAR(-/-) mice indicating that in these mice infection always progressed to death. HVP2ap replicated in the skin at the site of inoculation and invaded dorsal root ganglia as efficiently as HVP2nv in IFNAR(-/-) mice. Since the virion host shutoff (vhs) protein encoded by the UL41 gene of herpes simplex virus has been implicated in circumventing the host IFN-beta response and the phenotype of UL41 deletion mutants of HSV is very similar to that of HVP2ap isolates, the UL41 gene was deleted from HVP2nv (Delta 41) and replaced with the UL41 ORF from HVP2ap (Delta 41C). Like the parental HVP2nv virus, the Delta 41C recombinant replicated efficiently in Balb/c PMDFs and did not induce a strong IFN-beta response. The neuropathogenicity of the Delta 41C recombinant was also the same as the parental HVP2nv virus in Balb/c mice, indicating that the vhs protein does not underlie the different neuropathogenic phenotype of HVP2ap and HVP2nv. In contrast, the Delta 41 deletion virus induced a strong IFN-beta response but was still able to undergo multiple rounds of replication in PMDF cultures, albeit at a slower pace than the parental HVP2nv. This was reflected in vivo as the Delta 41 mutant had an LD(50) equivalent to that of the parental HVP2nv virus although the time to death was longer. These results indicate that while the vhs protein is involved in preventing and/or suppressing an IFN-beta response, it is not responsible for the ability of HVP2nv to overcome IFN-beta induced resistance of uninfected cells and does not underlie the divergent pathogenicity of the two HVP2 subtypes in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215952      PMCID: PMC2729440          DOI: 10.1016/j.virol.2009.01.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  Temporal progression of viral replication and gross and histological lesions in Balb/c mice inoculated epidermally with Saimiriine herpesvirus 1 (SaHV-1).

Authors:  M A Breshears; R Eberle; J W Ritchey
Journal:  J Comp Pathol       Date:  2005 Aug-Oct       Impact factor: 1.311

2.  Analysis of conserved domains of UL41 of herpes simplex virus type 1 in virion host shutoff and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle.

Authors:  L Strelow; T Smith; D Leib
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

Review 4.  The simian herpesviruses.

Authors:  R Eberle; J Hilliard
Journal:  Infect Agents Dis       Date:  1995-06

5.  Shedding and transmission of baboon Herpesvirus papio 2 (HVP2) in a breeding colony.

Authors:  R Eberle; D H Black; T W Lehenbauer; G L White
Journal:  Lab Anim Sci       Date:  1998-02

6.  Prevalence of Herpesvirus papio 2 in baboons and identification of immunogenic viral polypeptides.

Authors:  R Eberle; D H Black; E L Blewett; G L White
Journal:  Lab Anim Sci       Date:  1997-06

7.  Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.

Authors:  T J Smith; C E Ackland-Berglund; D A Leib
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants.

Authors:  Tracy J Smith; Lynda A Morrison; David A Leib
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 9.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

10.  Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.

Authors:  Jenny A Murphy; Rebecca J Duerst; Tracy J Smith; Lynda A Morrison
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more
  4 in total

1.  Role of the virion host shutoff protein in neurovirulence of monkey B virus (Macacine herpesvirus 1).

Authors:  Darla Black; Jerry Ritchey; Mark Payton; Richard Eberle
Journal:  Virol Sin       Date:  2014-10-22       Impact factor: 4.327

2.  A single viral gene determines lethal cross-species neurovirulence of baboon herpesvirus HVP2.

Authors:  Darla Black; Kazutaka Ohsawa; Shaun Tyler; Lara Maxwell; R Eberle
Journal:  Virology       Date:  2014-01-29       Impact factor: 3.616

3.  Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus).

Authors:  Lauren A Brush; Darla H Black; Kimberly A Mccormack; Lara K Maxwell; George Wright; Jerry W Ritchey; Mark E Payton; Richard Eberle
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

4.  Effective Prophylactic Therapy for Exposure to Monkey B Virus (Macacine alphaherpesvirus 1).

Authors:  Lara K Maxwell; Darla H Black; George E Wright; Melanie A Breshears; Richard Eberle
Journal:  Comp Med       Date:  2019-12-06       Impact factor: 1.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.